49K
$1B
87K$1B
73K$1B
78K$1B
38K$1B
93K$1B
36K$1B
102K$1B
54K$1B
103K$1B
60K$1BEntasis Therapeutics uses 8 technology products and services including SiteCatalyst, WordPress, AngularJS, and more. Explore Entasis Therapeutics's tech stack below.
| Entasis Therapeutics Email Formats | Percentage |
| First.Last@entasistx.com | 80% |
| Last.First@entasistx.com | 11% |
| Last@entasistx.com | 5% |
| First.Middle@entasistx.com | 4% |
Biotechnology ResearchMassachusetts, United States51-200 Employees
Entasis Therapeutics, a subsidiary of Innoviva, Inc., is developing a portfolio of innovative cures for serious drug-resistant bacterial infections, a global health crisis affecting the lives of millions of patients. Our deep pipeline of novel clinical and preclinical antibacterial programs is designed to revolutionize the way physicians treat serious bacterial diseases.
Company Overview
Media & News
Funding & FinancialsEntasis Therapeutics has raised a total of $157M of funding over 3 rounds. Their latest funding round was raised on Sep 01, 2018 in the amount of $75Mas a IPO.
Entasis Therapeutics's revenue is in the range of $10M$50M
Funding & FinancialsEntasis Therapeutics has raised a total of $157M of funding over 3 rounds. Their latest funding round was raised on Sep 01, 2018 in the amount of $75Mas a IPO.
Entasis Therapeutics's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com